期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 824, 期 -, 页码 185-192出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2018.01.034
关键词
Diabetic nephropathy; Exosomes; Podocyte; Berberine; TGF beta 1
资金
- National Natural Science Foundation of China [81773955, 81102864]
- Anhui Provincial Natural Science Foundation (China) [1508085MH179]
- Chinese Traditional Medical Research of Anhui Province (China) [2016zy08]
Diabetic nephropathy is the most common microvascular complications of diabetes. Berberine is the main active ingredient of Coptis chinensis and previous studies have been showed that berberine could delay the progression of diabetic nephropathy by regulating related cytokines and signaling pathways. Glomerular mesangial cells and podocytes are two vital indigenous cells of kidney and interaction between these two cellular components via exosomes might affect function of glomerulus in diabetic nephropathy condition. On the basis of our previous studies, transwell systems were used to demonstrate that the exosomes released by glomerular mesangial cells induced by the high glucose were involved in podocytes injury. The current study demonstrates that berberine can reduce TGF beta 1 in exosomes released by high glucose-induced glomerular mesangial cells. Berberine-treated high glucose-induced exosomes which are secreted by glomerular mesangial cells can protect damage of podocytes by reducing apoptosis and increasing adhesion. These results suggest that berberine could protect the function of podocytes through inhibiting the transfer of TGF beta 1 from the glomerular mesangial cells to the podocytes, which is one of the potential mechanisms of protective effect of berberine on diabetic nephropathy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据